Pay in 4 interest-free payments of $6.98 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Semaglutide is a GLP-1 receptor agonist that helps regulate blood sugar and appetite
Carefully Prepared Products Place your order online and complete a quick health form
Use: To reduce the risk of sustained estimated eGFR decline, ESRD, and CV death in patients with type 2 diabetes mellitus and chronic kidney disease Usual Adult Dose for Metabolic Dysfunction-Associated Steatohepatitis Wegovy injection: Initial dose (weeks 1 through 4): 0.25 mg subcutaneously once a week Dose escalation: Weeks 5 through 8: 0.5 mg subcutaneously once a week Weeks 9 through 12: 1 mg subcutaneously once a week Weeks 13 through 16: 1.7 mg subcutaneously once a week If 2.4 mg is not tolerated: 1.7 mg subcutaneously once a week
Additionally, semaglutide slows down stomach emptying, reducing the amount of sugar absorbed from food, and increases the feeling of fullness
Since semaglutides work to slow the transit of food in your body, alcohol in small doses may be counterproductive while alcohol in large doses could compound digestive issues like constipation
Less common but serious side effects of Semaglutide include: kidney problems, diabetic retinopathy, allergic reactions, low blood sugar, and pancreatitis
